CSI Market
Sign In | Register

Elite Pharmaceuticals Inc (ELTP) Annual Balance Sheets

Annual · GAAP · USD millions
Access ELTP quarterly Balance Sheets →
A period-by-period view of the balance sheet from Elite Pharmaceuticals Inc to Mar 31 2022 helps clarify how Mar 31 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Mar 31 2025) (Mar 31 2024) (Mar 31 2023) (Mar 31 2022)
Assets
Cash & cash equivalent29.80
Security Deposit0.09
Cash & Short-term Investments29.00
Accounts receivable59.72
Inventories21.26
Prepaid Expense And Other Assets Current1.33
Total Current Assets112.11
Equipment/Property/Plant Net28.28
Intangible Assets4.79
Long-term investments0.00
Tax Assets, Noncurrent17.15
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset2.00
Total Assets138.29
Liabilities
Accounts Payable, Current AC6.05
Accrued Liabilities, Current AC10.19
Derivative Liability, Current DE0.28
Short-term Debt0.09
Other Liabilities, Current0.17
Taxes Payable0.59
Total Current Liabilities17.39
Long-term debt2.15
Secured Debt0.65
Total Long-term Debt2.15
Derivative Liability, Noncurrent DE17.34
Accrued Income Taxes, Noncurrent1.51
Other liabilities, Noncurrent1.01
Operating Lease Liability Current0.47
Derivative Liability Warrants-
Total Liabilities39.41
Stockholders' Equity
Common Stock Value1.08
Treasury Stock Value0.31
Additional Paid In Capital Common Stock173.94
Retained Earnings / Accumulated Deficit-75.83
Other Equity0.00
Common Stockholder's Equity98.88
Total Stockholder's Equity98.88
Liabilities & Stockholder's Equity138.29
4 historic quarters locked

Sign in to unlock the full Elite Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Elite Pharmaceuticals Inc Nv Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20260331)
  • Filed with the SEC: June 29, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-031070

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.